Literature DB >> 9112024

Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients.

C Müller1, F Assimacopoulos-Jeannet, F Mosimann, P Schneiter, J P Riou, C Pachiaudi, J P Felber, E Jéquier, B Jeanrenaud, L Tappy.   

Abstract

Resting, post-absorptive endogenous glucose production (EGP), fractional gluconeogenesis and liver glycogen concentration were assessed in 6 lean and 5 obese non-diabetic subjects undergoing elective abdominal surgery. During the 2 days preceding these measurements, 0.3 g/day U-13C glucose had been added to their usual diet to label their endogenous glycogen stores. On the morning of day 3, EGP was measured with 6,6-2H glucose. Their endogenous 13C glycogen enrichment was calculated from 13CO2 and respiratory gas exchanges. Fractional gluconeogenesis was assessed as 1-(13C glucose/13C glycogen)100. EGP was similar in lean subjects (113 +/- 5 mg/min) and in obese subjects (111 +/- 6). Fractional gluconeogenesis was higher in obese (59 +/- 10%) than in lean subjects (29 +/- 8%). However, overall EGP remained constant due to a decrease in glycogenolysis. Since an increased gluconeogenesis and a decreased glycogenolysis may both contribute to increase liver glycogen concentration in obesity, hepatic glycogen concentrations were assessed in hepatic needle biopsies obtained during surgery. Hepatic glycogen concentrations were increased in obese patients (515 +/- 38 mg/g protein) compared to lean subjects (308 +/- 58, p < 0.05). It is concluded that in obese patients: a) fractional gluconeogenesis is increased; b) overall EGP is unchanged due to a proportional inhibition of glycogenolysis; c) liver glycogen concentration is increased.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9112024     DOI: 10.1007/s001250050701

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

1.  Effect of macronutrients, age, and obesity on 6- and 24-h postprandial glucose metabolism in cats.

Authors:  Margarethe Hoenig; Erin T Jordan; John Glushka; Saskia Kley; Avinash Patil; Mark Waldron; James H Prestegard; Duncan C Ferguson; Shaoxiong Wu; Darin E Olson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-21       Impact factor: 3.619

2.  Monounsaturated fat rapidly induces hepatic gluconeogenesis and whole-body insulin resistance.

Authors:  Theresia Sarabhai; Sabine Kahl; Julia Szendroedi; Daniel F Markgraf; Oana-Patricia Zaharia; Cristina Barosa; Christian Herder; Frithjof Wickrath; Pavel Bobrov; Jong-Hee Hwang; John Griffith Jones; Michael Roden
Journal:  JCI Insight       Date:  2020-05-21

3.  Inhibition of glycogenolysis in primary rat hepatocytes by 1, 4-dideoxy-1,4-imino-D-arabinitol.

Authors:  B Andersen; A Rassov; N Westergaard; K Lundgren
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

4.  The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.

Authors:  Birgitte Andersen; Niels Westergaard
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

5.  Hepatic glucose production pathways after three days of a high-fat diet.

Authors:  Eunsook S Jin; Sara A Beddow; Craig R Malloy; Varman T Samuel
Journal:  Metabolism       Date:  2012-09-12       Impact factor: 8.694

6.  MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST).

Authors:  Peter C M van Zijl; Craig K Jones; Jimin Ren; Craig R Malloy; A Dean Sherry
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

7.  Carbenoxolone treatment ameliorated metabolic syndrome in WNIN/Ob obese rats, but induced severe fat loss and glucose intolerance in lean rats.

Authors:  Siva Sankara Vara Prasad Sakamuri; Mahesh Sukapaka; Vijay Kumar Prathipati; Harishankar Nemani; Uday Kumar Putcha; Shailaja Pothana; Swarupa Rani Koppala; Lakshmi Raj Kumar Ponday; Vani Acharya; Giridharan Nappan Veetill; Vajreswari Ayyalasomayajula
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

8.  Butyrate ingestion improves hepatic glycogen storage in the re-fed rat.

Authors:  Marie-Christine Beauvieux; Hélène Roumes; Nadège Robert; Henri Gin; Vincent Rigalleau; Jean-Louis Gallis
Journal:  BMC Physiol       Date:  2008-10-10

9.  Prolonged fasting-induced metabolic signatures in human skeletal muscle of lean and obese men.

Authors:  Ann Mosegaard Bak; Mikkel Holm Vendelbo; Britt Christensen; Rikke Viggers; Bo Martin Bibby; Jørgen Rungby; Jens Otto Lunde Jørgensen; Niels Møller; Niels Jessen
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

10.  AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease.

Authors:  Nikolaos Nikolaou; Laura L Gathercole; Lea Marchand; Sara Althari; Niall J Dempster; Charlotte J Green; Martijn van de Bunt; Catriona McNeil; Anastasia Arvaniti; Beverly A Hughes; Bruno Sgromo; Richard S Gillies; Hanns-Ulrich Marschall; Trevor M Penning; John Ryan; Wiebke Arlt; Leanne Hodson; Jeremy W Tomlinson
Journal:  Metabolism       Date:  2019-07-19       Impact factor: 8.694

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.